Search research articles
Contact Us
Filters
Showing results (271-280 of 404) with videos related to
Page
of 41
Sort By:
Journal of Viral Hepatitis
|
August 27, 2019
Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study
Beth Catlett, Francois M J Lamoury, Sahar Bajis, et al.
The Lancet. Gastroenterology & Hepatology
|
May 23, 2025
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles
Lindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, et al.
Journal of the International AIDS Society
|
February 13, 2019
A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015
Sofia R Bartlett, Tanya L Applegate, Brendan P Jacka, et al.
Journal of Addiction Medicine
|
October 25, 2016
Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia
Emmanuel Fortier, Maryam Alavi, Julie Bruneau, et al.
Plos One
|
September 2, 2016
Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men
Daniel Bradshaw, Jayna Raghwani, Brendan Jacka, et al.
Journal of Medical Virology
|
August 27, 2017
HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype
Samantha J Shepherd, Scott A McDonald, Norah E Palmateer, et al.
Emerging Infectious Diseases
|
July 24, 2025
Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia
Nicolas M Legrand, Rowena A Bull, Behzad Hajarizadeh, et al.
Plos One
|
November 10, 2011
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART
Jennifer Audsley, Eric C Seaberg, Joe Sasadeusz, et al.
Drug and Alcohol Dependence
|
December 12, 2018
Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies
Graham R Foster, Gregory J Dore, Stanley Wang, et al.
Open Forum Infectious Diseases
|
February 12, 2024
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination
Sophy T F Shih, Jack Stone, Natasha K Martin, et al.
Page
of 41
Search research articles
Search
Showing results (271-280 of 404) with videos related to
Sort By:
Page
of 41
Journal of Viral Hepatitis
|
August 27, 2019
Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study
Beth Catlett, Francois M J Lamoury, Sahar Bajis, et al.
The Lancet. Gastroenterology & Hepatology
|
May 23, 2025
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles
Lindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, et al.
Journal of the International AIDS Society
|
February 13, 2019
A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015
Sofia R Bartlett, Tanya L Applegate, Brendan P Jacka, et al.
Journal of Addiction Medicine
|
October 25, 2016
Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia
Emmanuel Fortier, Maryam Alavi, Julie Bruneau, et al.
Plos One
|
September 2, 2016
Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men
Daniel Bradshaw, Jayna Raghwani, Brendan Jacka, et al.
Journal of Medical Virology
|
August 27, 2017
HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype
Samantha J Shepherd, Scott A McDonald, Norah E Palmateer, et al.
Emerging Infectious Diseases
|
July 24, 2025
Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia
Nicolas M Legrand, Rowena A Bull, Behzad Hajarizadeh, et al.
Plos One
|
November 10, 2011
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART
Jennifer Audsley, Eric C Seaberg, Joe Sasadeusz, et al.
Drug and Alcohol Dependence
|
December 12, 2018
Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies
Graham R Foster, Gregory J Dore, Stanley Wang, et al.
Open Forum Infectious Diseases
|
February 12, 2024
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination
Sophy T F Shih, Jack Stone, Natasha K Martin, et al.
Page
of 41